 IRIDEX NASDAQ:IRIX was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. The brokerage currently has a 2.25 price target on the medical equipment providers stock. Zacks Investment Researchs target price indicates a potential upside of 7.14 from ... 